193P First-line liposomal irinotecan + 5 fluorouracil/leucovorin + oxaliplatin in patients with pancreatic ductal adenocarcinoma: Exploratory survival analyses by change in post treatment CA 19-9

A Dean,T Bekaii-Saab,P.M Boland,F Dayyani,T Macarulla Mercade,K Mody,B Belanger,F Maxwell,Y Moore,T Wang,B Zhang,Z.A Wainberg

doi:10.1016/j.annonc.2020.10.457

193P First-line liposomal irinotecan + 5 fluorouracil/leucovorin + oxaliplatin in patients with pancreatic ductal adenocarcinoma: Exploratory survival analyses by change in post treatment CA 19-9

A Dean, T Bekaii-Saab + Show 10 more

Open Access

https://doi.org/10.1016/j.annonc.2020.10.457

Copy DOI

Journal: Annals of oncology : official journal of the European Society for Medical Oncology	Publication Date: Nov 1, 2020
License type: publisher-specific-oa

Affiliation: St John of God Subiaco Hospital, Mayo Clinic, Winneshiek Medical Center, University of California, Irvine Medical Center, Vall d'Hebron Institute of Oncology, AVEO Oncology (United States), Ipsen (United States), Ipsen (United Kingdom)

#Exploratory Survival Analyses #Oxaliplatin In Patients + Show 6 more

Abstract
Full-Text PDF
Similar Papers

Abstract

193P First-line liposomal irinotecan + 5 fluorouracil/leucovorin + oxaliplatin in patients with pancreatic ductal adenocarcinoma: Exploratory survival analyses by change in post treatment CA 19-9

Full Text